Table 1.
Scaffold | Method | Associated Tissue Engineering Strategy | Regeneration Level * | Findings | Reference | |||||
---|---|---|---|---|---|---|---|---|---|---|
Peptide-amphiphile (PA) hydrogel self-assembling | In vitro | - | DPSCs & SHEDs human | 1 |
|
Galler et al., 2008 [41]. | ||||
Peptide hydrogel | In vivo | VEGF, TGF-β1 & FGF-1 | DPSCs human | 1 | 2 | 3 |
|
Galler et al., 2011 [42]. | ||
Peptide hydrogel multidomain peptides (MDP) self-assembling | In vitro | FGF, TGF-β1 &VEGF | DPSCs human | 1 | 3 |
|
Galler et al., 2012 [43]. | |||
PCL | In vivo | Neural growth factor | mouse | 5 |
|
Eap et al., 2014 [56]. | ||||
Polydioxanone II (PDS II) | In vitro | MET or CIP | hDPSCs Human |
1 |
|
Bottino et al., 2013 [57]. | ||||
Collagen | In vivo | BMP-2 and 4 & TGF-β1 | Dog | 1 | 2 |
|
Nakashima, 1994 [58]. | |||
In vivo | CP & DMP-1 | DPSCs human |
1 |
|
Prescott et al., 2008 [59]. | |||||
In vivo | SDF-1 | Dog pulp CD 105+, CD31 SP cells | 1 |
|
Nakashima & lohara 2011 [60]. | |||||
In vivo | SDF-1 | Dog pulp CD105+ cells | 1 | 3 | 4 |
|
Iohara et al., 2011 [61]. | |||
In vivo | SDF-1 | Dog pulp, BM, Adipose CD31 SP cells | 1 | 3 | 4 |
|
Ishizaka et al., 2012 [62]. | |||
In vivo | G-CSF | hDPSCs human |
1 | 2 |
|
Murakami et al., 2013 [63]. | ||||
In vivo | G-CSF | Dog mobilized DPSCs | 1 | 2 |
|
Iohara et al., 2013 [64]. | ||||
In vivo | G-CSF | Dog mobilized DPSCs | 1 |
|
Iohara et al., 2014 [65]. | |||||
In vitro | - | hDPCs | 1 | 2 |
|
Kwon et al., 2017 [66]. | ||||
Gelatin hydrogel | In vitro | FGF-2 | Rat dental pulp | 1 | 3 |
|
Ishimatsu et al., 2009 [67]. | |||
Methacryloyl GelMA hydrogel | In vitro | OD21 ECFCs mouse |
1 | 3 |
|
Athirasala et al., 2017 [68]. | ||||
Fibrin gel | In vivo | PEG | DPSCs, SHEDs, PDLSCs BMSSCs human | 1 |
|
Galler et al., 2011 [69]. | ||||
Platelet-rich fibrin (PRF) | In vitro | GFs | DPSC dog | 1 | 3 |
|
Chen et al., 2015 [70]. | |||
In vitro | GFs | hDPCs | 2 |
|
He et al., 2016 [71]. | |||||
In vitro | MTA | hDPCs | 2 |
|
Woo et al., 2016 [72]. | |||||
PRF or Platelet—rich plasma (PRP) | Clinical | - | human | 1 | 3 |
|
Shivashankar et al., 2017 [73]. | |||
Alginate hydrogel | In vitro | TGF-β1 | human | 1 | 2 |
|
Dobie et al., 2002 [74]. | |||
Alginate hydrogel | In vitro | - | SCAPs | 1 |
|
Lambricht et al., 2014 [75]. | ||||
Alginate | In vitro | - | DPSCs human | 1 | 2 |
|
Sancilio et al., 2018 [76]. | |||
Chitosan | In vitro | β-tricalcium phosphate | HPLCs human |
2 | 3 |
|
Liao et al., 2010 [77]. | |||
Chitosan | In vitro | 1α,25-dihydroxyvitamin D3 (1α,25VD) Calcium-aluminate | DPCs human | 1 | 2 |
|
Bordini et al., 2019 [78]. | |||
Chitosan | In vitro | Silver Bioactive glass |
DPCs | 1 | 2 |
|
Zhu et al., 2019 [79]. | |||
Poly-L-lysine | In vitro | α-MSH | Rat-human | 1 |
|
Fioretti et al., 2010 [80]. Fioretti et al., 2011 [81]. |
||||
Poly(L-lactic acid) PLLA |
In vitro
In vivo |
- | DPSCs human | 1 |
|
Wang et al., 2011 [82]. | ||||
PLGA | In vitro | - | DPCs human | 1 | 2 |
|
Zou et al., 2016 [83]. | |||
PLGA | In vitro | - | DPSCs | 1 |
|
Gangolli et al., 2019 [84]. |
* Regeneration Levels; 1: Pulp Connective-tissue Formation, 2: Dentin Formation, 3: Revascularization, 4: Reinnervation, 5: Radicular Edification. Abbreviations: α-MSH: α-Melanocyte Stimulating Hormone, ALP: alkaline phosphatase, BM: bone marrow, BMP: bone morphogenetic protein, CIP: Ciprofloxacin, CP: ceramic powder, DMP-1: dentin matrix protein 1, DPSCs: dental pulp stem cells, ECFCs: endothelial colony forming cells, Ef: enterococcus faecalis, FGF-2: fibroblast growth factor 2, G-CSF: granulocyte colony-stimulating factor, GF: growth factor, hDPCs: human dental pulp cells, hDPSCs: human dental pulp stem cells, HPLCs: human periodontal ligament cells, MET: metronidazole, MTA: mineral trioxide aggregate, OD21: odontoblast-like cells, OPN: osteopontin, Pj: porphyromonas gingivalis, SDF-1: stromal-cell-derived factor-1, SHEDs: stem cells from human exfoliated deciduous teeth, SP: side-population, TGF-β1: transforming growth factor β 1, VEGF: vascular endothelial growth factor.